Trichosporon ocular infections: Genotyping, antifungal susceptibility, clinico-microbiological correlation, and literature review
Indian Journal of Ophthalmology · 2026-08 · 74 (Suppl 2) · S221-S231
DOI: 10.4103/ijo.ijo_3192_25 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 03.08.2026. Verfasst von Sanchita Mitra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Microbiology, Jhaveri Microbiology Centre and Prof. Brien Holden Eye Research Centre, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyder…. Hauptthemen laut MEDLINE: Trichosporon, Eye Infections, Fungal, Antifungal Agents, Trichosporonosis. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Ocular infections caused by Trichosporon spp., a yeast-like fungus and an emerging fungal pathogen associated with severe invasive disease and poor outcomes, remain underexplored, with only a few case reports available. We present a decade-long case series of Trichosporon ocular infections, describing clinical features, detailed microbiology, clinico-microbiological correlations, antifungal susceptibility patterns, and genotyping of isolates. A comprehensive literature review of all reported cases to date is also included.
Methods
A retrospective review of electronic medical records (EMRs) identified eight cases of Trichosporon ocular infections over a 12-year period. Demographic, clinical, and microbiological data were extracted from EMRs. Five stored isolates were retrieved from −80°C stocks for genotyping by Sanger sequencing and in-vitro antifungal susceptibility testing. Relevant statistical analyses were performed to assess clinico-microbiological correlations.
Results
Fifty percent of patients had favorable clinical outcomes. Trichosporon asahii was the most common species isolated and was associated with poorer outcomes compared to T. inkin . Multidrug resistance (MDR) was frequent and correlated with worse prognosis. Natamycin was the most frequently administered antifungal agent, followed by azoles. Microbiological confirmation guided initiation of antifungal therapy in half of the cases. Sanger sequencing corrected species misidentifications made by the Vitek2 Compact system.
Conclusions
Trichosporon ocular infections remain rare but can affect both immunocompromised and immunocompetent individuals. Poor outcomes were associated with MDR strains and pre-existing ocular conditions. Azoles demonstrated better therapeutic responses compared to other antifungal agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ocular Microbiology, Jhaveri Microbiology Centre and Prof. Brien Holden Eye Research Centre, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India.
- Medical Microbiology, Central Laboratory, Mamata Academy of Medical Sciences, Hyderabad, Telangana, India.
- Cornea and Anterior Segment, Shantilal Sanghvi Cornea Institute, LV Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India.
- Cornea and Anterior Segment Services, Shantilal Shanghvi Eye Institute, Mumbai, Maharashtra, India.
Zitieren
APA
Mitra, S., & Murthy, S. (2026). Trichosporon ocular infections: Genotyping, antifungal susceptibility, clinico-microbiological correlation, and literature review. Indian Journal of Ophthalmology, 74(Suppl 2), S221-S231. https://doi.org/10.4103/ijo.ijo_3192_25
Vancouver
Mitra S, Murthy S. Trichosporon ocular infections: Genotyping, antifungal susceptibility, clinico-microbiological correlation, and literature review. Indian Journal of Ophthalmology. 2026;74(Suppl 2):S221-S231. doi:10.4103/ijo.ijo_3192_25
BibTeX
@article{Mitra2026,
author = {Mitra, Sanchita and Murthy, Somasheila},
title = {Trichosporon ocular infections: Genotyping, antifungal susceptibility, clinico-microbiological correlation, and literature review},
journal = {Indian Journal of Ophthalmology},
year = {2026},
volume = {74},
number = {Suppl 2},
pages = {S221--S231},
doi = {10.4103/ijo.ijo_3192_25}
}
EUVIMED